期刊
STROKE
卷 41, 期 10, 页码 S99-S102出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.110.597476
关键词
clinical trials; intracerebral hemorrhage; neuroprotection
资金
- NIA NIH HHS [AG 17604] Funding Source: Medline
- NINDS NIH HHS [NS 40409, NS 42167, NS56146] Funding Source: Medline
- PHS HHS [S 39512] Funding Source: Medline
- FDA HHS [FD 3728] Funding Source: Medline
Intracerebral hemorrhage is a devastating neurological illness with few treatment options. In the past 10 years, 6 clinical trials have been completed examining the potential role that putative neuroprotective agents might play in improving outcome. Although each of these trials failed to show a benefit, animal research continues to supply the translational pipeline and 5 clinical trials evaluating neuroprotective agents in intracerebral hemorrhage are currently ongoing. Despite initial failures, neuroprotective agents continue to show promise in the treatment of intracerebral hemorrhage, but improvements in clinical trial design and more accurate predictive outcome models are necessary. (Stroke. 2010;41[suppl 1]:S99-S102.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据